Skip to main content

Constipation News (Page 2)

Related terms: Difficulty passing stool, Irregularity of bowels

FDA Approves Movantik (naloxegol) for Opioid-Induced Constipation

September 16, 2014 – The U.S. Food and Drug Administration today approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain. Opioids are...

FDA Medwatch Alert: Sodium Phosphate Over-the-Counter Products: Drug Safety Communication - Possible Harm From Exceeding Recommended Dose

Marketed under the brand-name Fleet, and as store brands and generic products.   [Posted 01/08/2014] ISSUE: FDA is warning that using more than one dose in 24 hours of over-the-counter (OTC) sodium ...

FDA Approves Amitiza for Opioid-Induced Constipation

BETHESDA, Md. & DEERFIELD, Ill.--(BUSINESS WIRE)--Apr. 23, 2013-- Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. announced today that the United States (U.S.) Food and Drug...

FDA Approves Linzess to Treat Certain Cases of Irritable Bowel Syndrome and Constipation

August 30,2012 – The U.S. Food and Drug Administration today approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation (IBS-C)...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Constipation - Chronic, Constipation - Acute, Gastrointestinal Disorders

Related drug support groups

Peri-DS, MiraLax, magnesium citrate, Dulcolax, Metamucil, lactulose, Fleet Enema, Colace, Milk of Magnesia, bisacodyl